Home › Funds › Laurion Capital Management LP › AARD

Laurion Capital Management LP position in AARD

Aardvark Therapeutics Inc · Health Care

Laurion Capital Management LP reported holding 1,034,459 shares of AARD (Aardvark Therapeutics Inc) in its Q2 2026 13F filing — a position valued at US$6.0M, representing 0.33% of its reported portfolio and ranking #49 among its reported holdings. Laurion Capital Management LP has disclosed AARD holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)1.03M sh
Reported value held$5.96M
Portfolio Weight0.33%
First reportedQ1 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Laurion Capital Management LP's AARD position evolved

Laurion Capital Management LP first disclosed a stake in AARD in Q1 2025 at 808,243 shares (US$6.1M). The position peaked in Q3 2025 at 1,049,721 shares, worth US$14.0M. Across 6 filings, Laurion Capital Management LP increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,034,459 shares valued at US$6.0M.

Quarter by quarter

QuarterSharesValueChange
Q1 2025 808.24K $6.07M New
Q2 2025 989.07K $13.37M Add
Q3 2025 1.05M $13.95M Add
Q4 2025 1.01M $13.32M Reduce
Q1 2026 1.03M $3.90M Add
Q2 2026 1.03M $5.96M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AARD and 13F data

AARD (Aardvark Therapeutics Inc) is a Health Care company. 62 other funds we track also report a position in AARD — the largest reported positions include Decheng Capital LLC (US$22.6M), EcoR1 Capital, LLC (US$85K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AARD

All AARD fund holders →

FAQ

How long has Laurion Capital Management LP held AARD?

Laurion Capital Management LP has disclosed AARD holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Laurion Capital Management LP's current position in AARD?

As of Q2 2026, Laurion Capital Management LP holds 1.03M shares of AARD (Aardvark Therapeutics Inc), valued at $5.96M, representing 0.33% of its reported portfolio and ranking #49.

Has Laurion Capital Management LP been buying or selling AARD?

In the latest 13F filing (Q2 2026), Laurion Capital Management LP held unchanged its position in AARD. The position peaked in Q3 2025 at 1.05M shares.

Which other funds hold AARD?

Other major institutional holders of AARD include Decheng Capital LLC, EcoR1 Capital, LLC, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.